Arsenic trioxide for the treatment of acute promyelocytic leukaemia

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the role of arsenic trioxide (ATO) for treating patients with acute promyelocytic leukaemia in comparison with regimens without ATO.

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Xu, ShuangNian, Chen, JiePing, Liu, Jian Ping, Xia, Yun, Li, Xi, Tan, Ya
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2016
Konular:
Medicine General & Introductory Medical Sciences
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6463851/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008425.pub2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller